Ligand Pharmaceuticals
LGND
#4110
Rank
โ‚น177.77 B
Marketcap
โ‚น9,220
Share price
-0.44%
Change (1 day)
55.82%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.21

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น133.95. In 2022 the company made an earnings per share (EPS) of -โ‚น168.93 a decrease over its 2021 EPS that were of โ‚น295.20.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.21-175.89%
2022-โ‚น168.93-157.23%
2021โ‚น295.20-2571.43%
2020-โ‚น11.94-100.46%
2019โ‚น2,612353.48%
2018โ‚น575.901025%
2017โ‚น51.19-700%
2016-โ‚น8.53-100.87%
2015โ‚น986.281859.32%
2014โ‚น50.345.36%
2013โ‚น47.788.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น41.81-194.23%
2010-โ‚น44.37548.38%
2009-โ‚น6.84-98.7%
2008-โ‚น527.26-136.52%
2007โ‚น1,444-787.8%
2006-โ‚น209.88-14.58%
2005-โ‚น245.72-21.31%
2004-โ‚น312.26-55.15%
2003-โ‚น696.1981.33%
2002-โ‚น383.932.74%
2001-โ‚น373.69-45.93%
2000-โ‚น691.07-14.56%
1999-โ‚น808.81-45.52%
1998-โ‚น1,485-3.97%
1997-โ‚น1,546132.31%
1996-โ‚น665.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,207 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น30.71-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น298.67 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น155.42 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น158.69 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น463.22 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น338.71 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น436.83 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,202 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA